CCTV+: China-Lao Agricultural Science Cooperation Delivers New Results in 2025

BEIJING, Dec. 29, 2025 /PRNewswire/ — China and Lao PDR have stepped up…

HKSH Medical Group and Southern University of Science and Technology Collaborate for Medical and Medical Physics Training, Enhancing Medical Education and Research Innovation

HONG KONG, Dec. 29, 2025 /PRNewswire/ — HKSH Medical Group ("HKSH") and…

Shanghai unveils steps to build sci-tech innovation corridor in Yangtze River Delta

SHANGHAI, Dec. 29, 2025 /PRNewswire/ — A news report from english.shanghai.gov.cn A…

GEEKOM Returns to CES 2026 with Premium Laptops and Next-Generation Mini PCs

TAIPEI, Dec. 29, 2025 /PRNewswire/ — GEEKOM will make its fourth consecutive appearance at…

Global Times: Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era receives high recognition from intl community: 2025 Global Survey on Impression and Understanding of China

BEIJING, Dec. 29, 2025 /PRNewswire/ — In 2025, the world is undergoing…

ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange

Thai investors now can trade in real-time during local market hours using…

Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities

SHANGHAI, Dec. 29, 2025 /PRNewswire/ — Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become…

Alphamab Oncology Announces IND Application for a Phase II Clinical Study of HER2 Bispecific ADC Subcutaneous Co-formulation JSKN033 as First-line Treatment of Advanced Cervical Cancer was Officially Accepted by CDE

SUZHOU, China, Dec. 29, 2025 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK)…